Sepsis and Thrombocytopenia: A Nowadays Problem.

Area of Science:

• Critical Care Medicine
• Hematology
• Infectious Diseases

Background:

• Sepsis is a life-threatening organ dysfunction due to a dysregulated host response to infection, accounting for 15.6% of hospital mortality.
• Common sepsis signs include hypotension, tachypnea, fever, and leukocytosis.
• Thrombocytopenia, a significant sepsis complication, independently predicts worse patient outcomes, increased mortality, and longer intensive care unit (ICU) stays.

Purpose of the Study:

• To review the mechanisms underlying sepsis-associated thrombocytopenia.
• To discuss current and potential future treatments for patients with sepsis and thrombocytopenia.

Main Methods:

• Literature review of sepsis-associated thrombocytopenia.
• Analysis of proposed pathophysiological mechanisms.
• Examination of ongoing and proposed therapeutic strategies.

Main Results:

• Mechanisms range from decreased platelet production to disseminated intravascular coagulation (DIC).
• Current management focuses on supportive care: airway management, oxygenation, hydration, antibiotics, and vasopressors.
• Emerging treatments include GI antagonists (Phase I/II trials) and aspirin.

Conclusions:

• Sepsis-associated thrombocytopenia is a critical factor influencing patient prognosis.
• Understanding diverse mechanisms is key to developing targeted therapies.
• Future treatments hold promise, with ongoing trials exploring novel agents and repurposed drugs like aspirin.